{"podcast":{"title":"GLP-1 Hub: Support, Community, and Weight Loss","slug":"glp-1-hub-support-community-and-weight-loss-7228656","podcast_index_feed_id":7228656,"rss_url":"https://rss.buzzsprout.com/2455627.rss","website_url":"https://www.glp-1hub.com","image_url":"https://storage.buzzsprout.com/o4ga8nvw64k8owsm9a3l5gcwuv0o?.jpg","author":"Ana Reisdorf, MS, RD","episode_count":115,"summary":"Join Ana Reisdorf, dietitian and GLP-1 user, where science meets support, and your weight loss journey is backed by a community that gets it . Whether you're new to GLP-1 medications like Zepbound, Wegovy, Mounjaro or Ozempic, or just looking to optimize your results, this podcast is your trusted space for expert insights, real success stories, and practical strategies to help you feel your best.","last_synced_at":"2026-09-07T14:20:22.857712+00:00","page_url":"https://stenobird.com/podcast/glp-1-hub-support-community-and-weight-loss-7228656"},"episode":{"title":"6 Years Into GLP-1s: What Maintenance Really Looks Like w/ Tara Rothenhoefer","slug":"6-years-into-glp-1s-what-maintenance-really-looks-like-w-tara-rothenhoefer","published_at":"2026-07-30T07:00:00+00:00","page_url":"https://stenobird.com/podcast/glp-1-hub-support-community-and-weight-loss-7228656/6-years-into-glp-1s-what-maintenance-really-looks-like-w-tara-rothenhoefer","show_page_url":"https://stenobird.com/podcast/glp-1-hub-support-community-and-weight-loss-7228656","url":"https://pscrb.fm/rss/p/www.buzzsprout.com/2455627/episodes/19571326-6-years-into-glp-1s-what-maintenance-really-looks-like-w-tara-rothenhoefer.mp3","audio_url":"https://pscrb.fm/rss/p/www.buzzsprout.com/2455627/episodes/19571326-6-years-into-glp-1s-what-maintenance-really-looks-like-w-tara-rothenhoefer.mp3","summary":"Send us Fan Mail Tara Rothenhoefer was one of the earliest participants in a tirzepatide clinical trial, before the medication had a brand name. After a lifelong battle with obesity, she began the trial in 2020 at 342 pounds. Eighteen months later, she had lost 132 pounds. But when the study ended, she faced a year without medication, uncertainty around access, and the emotional work of learning how to live in a body she had never known before. In this episode, Tara shares what changed when ...","meta_description":"Send us Fan Mail Tara Rothenhoefer was one of the earliest participants in a tirzepatide clinical trial, before the medication had a brand name. After a l…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2780,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/glp-1-hub-support-community-and-weight-loss-7228656/episodes/6-years-into-glp-1s-what-maintenance-really-looks-like-w-tara-rothenhoefer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/glp-1-hub-support-community-and-weight-loss-7228656/6-years-into-glp-1s-what-maintenance-really-looks-like-w-tara-rothenhoefer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}